of cigarette smoking and the risk of total dementia, and a significant excess risk was found for smoking duration of 6 45 years. Conclusions: The present prospective study suggests that long-term cigarette smoking may raise the risk of disabling dementia.
associated with a reduced risk of dementia [6] . However, this inverse association between smoking and dementia might have been caused by the introduction of differential survival biases [6, 7] . Smokers are likely to have been underrepresented in these studies because of their increased risk of early death from cardiovascular disease and cancer [8] . In addition, individuals with dementia might have tended to underreport their smoking habits [6, 7] . These biases could have distorted the reported associations between smoking and dementia [6, 7] . Thus, owing to the methodological limitations of case-control studies, there is a requirement for prospective studies to examine the association between smoking and dementia.
Some recent prospective cohort studies have suggested that smokers have an approximately 1.4-fold to 1.7-fold increased risk of dementia compared with individuals who have never smoked [6, [9] [10] [11] , although other studies of this type have shown no such association [6] . The aim of the present nested case-control study was to investigate the association between cigarette smoking and the risk of disabling dementia using prospective data from members of a Japanese rural community.
Materials and Methods
The study cohort was established in the town of Kyowa (Ibaraki Prefecture, Japan) in 1981 for a community-based cardiovascular prevention program. The design of the cohort study has been described previously [12, 13] . This cohort has been followed up with annual cardiovascular surveys, and surveillance for incidence and mortality of stroke and coronary heart disease. Within this cohort, elderly persons aged 6 65 years with disabling dementia requiring care were identified under the national longterm care insurance program, between April 1, 2000 and March 31, 2004. We did not have information on cognitive function prior to dementia. However, in order to reduce the potential effects of as yet undiagnosed dementia at the time of a given cardiovascular survey, the cohort included 6,343 men and women aged 35-85 years who participated in the surveys between 1981 and 1994 (of these, 4,085 subjects were over 65 years old between 2000 and 2004). Of these, 1,156 subjects were dead and 252 subjects had moved out of the study area before March 31, 2004 . The overall participation rate was 70%. The Ethics Committee of the University of Tsukuba, Japan, approved the study procedures.
Long-Term Care Insurance Program for Elderly Aged 6 65
The details of the national long-term care insurance program for elderly aged 6 65 have been reported elsewhere [14, 15] . In brief, the insurance program was started in Japan from April 2000. This program was essentially extended from the national health insurance system, and partially relied on subsidies from general revenues from the national government, prefectures and municipalities. All individuals aged 6 40 are required to pay a supplement to their health insurance, which is transferred to the long-term care. The payment is directly withdrawn from their monthly income, shared with the employer or deducted from their public pensions. All individuals are able to receive a longterm care through their resided municipals when they become 65 and older and also if they have disabling dementia and/or reduced activity of daily living.
Case-Control Analysis
Case Selection The cases were selected among the subjects aged 6 65 years between 2000 and 2004 who were regarded as suffering from dementia under the long-term insurance program. The dementia status was classified into six ranks (0-V) and was reported by their primary care physicians according to the standardized physicians' manual issued by the Health and Welfare Bureau for the Elderly of Japan [16] . The dementia status was annually updated and was reviewed until the patients were withdrawn due to death or moving out of the study area. Individuals without dementia were classified as rank 0. Individuals who were diagnosed with mild cognitive dysfunction, but who had no dementia-related symptoms or behavioral disturbance and were capable of living independently, were classified as rank I. Individuals who had moderate dementia-related behavioral disturbance and cognitive impairment with slight dependence were classified as rank II. Individuals who had moderate to severe dementia-related behavioral disturbance and cognitive impairment with moderate dependence were classified as rank III. Individuals who had severe dementia-related behavioral disturbance and cognitive impairment with heavy dependence were classified as rank IV. Finally, individuals with severe dementia-related behavioral disturbance and cognitive impairment who required medical treatment were classified as rank V. Individuals who were ranked as II or greater for the first time were regarded as cases in the present analysis. The validation for the cut-off point was examined by neuropsychiatrists through the subjects' cognitive functions (attention, memory, visuospatial function, language and reasoning) based on their ageing-associated cognitive decline, as defined by the International Psychogeriatric Association [17] . The calculated sensitivity and specificity values from the validation study of 34 subjects were 36 and 90%, respectively.
History of Stroke Identification
The history of stroke was obtained from the annual cardiovascular surveys, surveillance for cardiovascular disease [13] from 1981 to the present, and/or statements from the primary care physicians. In the present study, 85% of the stroke history was confirmed based on CT or MRI using standardized criteria [18] . The determination of stroke history without the imaging studies was conducted based on the clinical criteria [19] . Stroke was defined as rapid-onset focal neurological disorder persisting for 6 24 h, or until death. Transient ischemic attack was not included.
Control Selection
We employed the risk set sampling [20] of controls, i.e. matching randomly each case of dementia with two of all other individuals with no diagnosis of dementia in the study cohort who were alive and resided within the community on the date of diagnosis of dementia for the case and who had the same gender, year of given annual cardiovascular survey and age ( 8 2 years) as the case. The vital status of controls was assessed before control selection.
Measurement of Risk Factors
Participants were interviewed concerning their smoking status (current, past, or never); those who smoked cigarettes were asked their age at start of smoking and the average daily number of cigarettes smoked at the time of a given annual cardiovascular survey. Those who had not smoked for 3 months or more were defined as past smokers. The past smokers were asked for their age at starting and quitting smoking, and the average daily number of cigarettes smoked. For each case, the latest measurements from a given survey between 1981 and 1994 were selected for the analysis. For controls, the measurements included in the analysis were selected from the same year of a given survey as the case.
The reliability of smoking questionnaire was tested in the same population. The proportion of upholding the same smoking status at 1 year after the time of a given survey between 1981 and 1994 (n = 2,314) was 97% for never smokers, 87% for past smokers, 93% for current smokers (83% for smokers of ! 20 cigarettes per day, and 75% for smokers of 6 20 cigarettes per day).
Confounding variables included systolic blood pressure (mm Hg), use of antihypertensive medication (yes and no), body mass index (BMI; kg/m 2 ), atrial fibrillation (Minnesota Codes 8-3-1 or 8-3-2), ST-T changes (Minnesota 4-1 to 4-3 or 5-1 to 5-3), ethanol intake (never drinkers, ex-drinkers, or current drinkers), serum cholesterol (m M ), and diabetes mellitus (a fasting glucose level of 1 7.0 m M , a nonfasting glucose level of 1 11.1 m M , or the use of medication for diabetes).
Statistical Analysis
The paired Student's t test was used to compare the values of baseline potential confounding factors and smoking status between incident cases and control subjects. The 2 test was used to compare proportions of cases and control subjects. The odds ratios of total and subtypes of dementia were estimated according to the smoking status, tertiles of smoking years and tertiles of pack-years of smoking using the conditional logistic regression model. Adjustments for systolic blood pressure (mm Hg), use of antihypertensive medication (yes vs. no), BMI, alcohol intake (noncurrent drinkers vs. current drinkers), atrial fibrillation (yes vs. no), ST-T abnormalities (yes vs. no), serum total cholesterol (m M ), and diabetes mellitus (yes vs. no) were applied for multivariable analysis. A trend across the categories for smoking years and pack-years of smoking was conducted by assigning median values for each category. To examine effect modification, we conducted stratified analyses according to sex and use of antihypertensive medication (yes and no), and checked statistical interactions by using cross-product terms of smoking status and stratifying variables. The presence of sex interaction for the associations between smoking and risk of dementia was tested using crossproduct terms of smoking status and sex variables. All p values for statistical tests were two-tailed and values ! 0.05 were considered to reflect significant difference. All analyses were conducted using the SAS statistical package version 8.2 (SAS Institute Inc., Cary, N.C., USA).
Results
During 2000-2004, we identified 208 dementia cases, comprising 95 dementia cases with a history of stroke and 113 dementia cases without such history. Table 1 shows the risk characteristics of dementia cases and control subjects. The average age at the time of a given annual cardiovascular survey and physical examination during 1981-1994 was 69 years for total and subtypes of dementia, and 68-69 years for controls. The proportion of men was 36% for total dementia, 42% for dementia with a history of stroke, 30% for dementia without such history, and 30-43% for controls. The proportions of current smokers were higher for total dementia than for controls. The prevalence of hypertension, diabetes, and ST-T abnormalities was higher for total and subtypes of dementia than for controls. These case-control differ- ences were more evident for dementia with a history of stroke than for dementia without such history. Table 2 shows age-, sex-, and survey year-matched and multivariable-adjusted odds ratios (95% CI) for total and subtypes of dementia according to smoking status. The multivariable odds ratios for current versus never smokers were 2.3 (1.1-4.7) for total dementia, 2.4 (0.8-7.7) for dementia with a history of stroke and 2.3 (0.9-6.0) for dementia without it. There was no significant excess risk among past smokers. We further analyzed the data by stratifying current smokers into two categories ( ! 20 and 6 20 cigarettes/day) and found a dose-response relationship for total dementia.
We also analyzed the data by stratifying past and current smokers into three categories according to the number of years of and the pack-years of smoking, and found a dose-response relationship with the number of years of smoking and risk of total dementia (p for trend = 0.04), but not with the pack-years of smoking (p for trend = 0.21; table 3 ). The dose-response relationship with the number of years of smoking was more pronounced for dementia with a history of stroke although the excess risk did not reach statistical significance.
We examined for potential effect modification by stratifying the analyses for sex and use of antihypertensive medication (yes and no; data not shown). There were no statistically significant interactions between smoking status and sex (p for interaction = 0.43) or use of antihypertensive medication (p for interaction = 0.80) for total dementia.
Discussion
Our prospective study is the first to show that current smoking is associated with a twofold increase in the risk of disabling dementia among Japanese. The association between smoking and risk of disabling dementia does not vary between persons with and without a history of stroke. The Pooled European Studies of Dementia reported that current smokers had an increased risk of total dementia (relative risk, RR = 1.4; 95% CI = 1.0-1.9) and Alzheimer's disease (RR = 1.7; 95% CI = 1.2-2.5) compared with individuals who had never smoked [9] . Another prospective study of mixed ethnic groups (African-Americans, Whites and Hispanics) in the USA reported that current smokers had an increased risk of Alzheimer's disease (RR = 1.7; 95% CI = 1.1-2.8) compared with those who had never smoked [10] . The Honolulu-Asia Ageing Study reported that current smokers had an increased risk of vascular dementia (odds ratio = 1.7; 95% CI = 1.0-2.9), but not for Alzheimer's disease, compared with those who had never smoked; however, this association was no longer significant after adjustment for cardiovascular and respiratory factors [11] .
A previous prospective study in Japan showed an association between smoking and increased risk of mortality from dementia [21] . That study followed 265,118 individuals aged 6 40 years over a period of 17 years, and documented 69 deaths from senile dementia with cerebrovascular lesions and 120 deaths from senile dementia without cerebrovascular lesions. The age-adjusted RR of senile dementia without cerebrovascular lesions for current smokers compared with never smokers was 1.6 (90% CI = 1.1-2.4), but no association was found between dementia with cerebrovascular lesions. However, that study did not adjust for potential confounding variables including blood pressure levels, and the diagnosis of dementia was not validated because the diagnosis relied only on death certificates.
A previous study found that the higher pack-year exposure was associated with greater cognitive decline among current and former smokers [22] . We found no Adjusted for BMI, alcohol use, serum total cholesterol, systolic blood pressure, use of antihypertensive medication, diabetes mellitus, atrial fibrillation and ST-T abnormality.
significant association between the pack-year exposure and risk of total dementia, either dementia with or without a history of stroke. However, we found an association between the number of years of smoking and the risk of total dementia, which may suggest that a long-term exposure rather than a high dose of smoking may increase the risk.
Several mechanisms could account for the adverse effect of smoking on the risk of vascular dementia. Smoking causes arterio-atherosclerosis by directly injuring endothelial cells [23] , it reduces high-density lipoprotein cholesterol levels [24] , and it accelerates thrombus formation by increasing plasma fibrinogen [25] and platelet aggregability [26] , decreasing fibrinolytic activities [27] , increasing hematocrit [28] and reducing blood flow in the brain due to vasoconstriction [29] .
Considering the association between smoking and Alzheimer's disease, a previous case-reference study showed that patients with this disorder and a history of smoking had lower regional cerebral blood flow in the temporal, parietal, occipital and frontal lobes bilaterally, compared with individuals who had never smoked [30] . When blood flow reaches a critical threshold of cerebral hypoperfusion, brain capillaries can be regionally damaged, and the normal release of nitric oxide and glucose, as well as oxygen delivery to the neurons, can be impaired [31] . These conditions can lead to cerebral metabolic dysfunction, which might contribute to the progression of neuronal degeneration [32] . Increased oxidative stress caused by smoking [33, 34] is another potential cause of Alzheimer's disease through enhanced neurotoxicity [35] .
Nicotine, which is a major component of tobacco smoke, has a neuroprotective effect via a reduction of amyloid aggregation and neurotoxicity [36] . However, any potential beneficial effect of nicotine is likely to be overwhelmed by the adverse effects of the other components of tobacco smoke [33] .
The strengths of our current study were its prospective design, and the comprehensive nature of cardiovascular surveys, which allowed that the association between smoking and risk of dementia is adjusted for important potential confounding variables. Moreover, because we used annual cardiovascular surveys that were carried out 6 5 years before the endpoint determination, severe dementia was unlikely to be present at the time of the risk factor assessment. This would enhance our confidence that smoking behavior was not influenced by subclinical dementia.
The major limitations of our study were as follows. First, there might have been a residual confounding effect on the association between smoking and risk of dementia. Although we adjusted for selected cardiovascular risk, we could not exclude the possible influence of unmeasured risk factors such as education level [37] and marital status [38] . Second, the misclassification for diagnosis of dementia was inevitable. The study had low sensitivity but high specificity for the diagnosis of disabling dementia. Thus, cases of disabling dementia were less likely to be contaminated by false-positive cases, but the false-negative cases were likely to exist in the control pool. However, due to the low prevalence of disabling dementia (approximately 5-6% of persons aged 6 65), the contamination by false-positive cases in the controls may be small. The controls could be contaminated by patients with mild cognitive impairments in the present study, which may attenuate the associations. Third, the smoking exposure could be misclassified due to self-reporting. However, previous studies showed that self-reported smoking was fairly reliable [39, 40] . In the present study, we examined answer-reanswer reliability with a 1-year interval between 1981 and 1994 and found that the reliability for self-reported smoking status was high; 97% for never smokers, 87% for past smokers, 93% for current smokers. Fourth, the smoking-dementia associations did not reach statistical significance when we examined two subtypes of dementia, probably due to the low statistical power to detect the effects. Fifth, there was a long duration between the time of recording smoking status and the time of dementia diagnosis, i.e. 6-21 years, which would make interpretation of the results difficult. However, the results did not change materially when the analyses were conducted, stratified by the time duration of 6-14 years (n = 461) and 15-21 years (n = 163). For example, odds ratios (95% CI) of total dementia in relation to current smokers were 1.8 (0.8-4.2) in the time duration of 6-14 years, and 2.0 (0.5-7.6) in the time duration of 15-21 years. There were no statistical interactions of two periods with smoking status, duration or the amount of smoking. Finally, we did not have imaging studies to confirm the subtypes of dementia, and dementia without a history of stroke did not necessarily correspond to Alzheimer's disease. However, the proportion of Alzheimer's disease sufferers among persons with dementia without a history of stroke was 79% in a previous Japanese study [41] , suggesting that dementia without a history of stroke in the present study is likely to be Alzheimer's disease. In contrast, only 2% of persons with a history of stroke had Alzheimer's disease in that study, suggesting that Alzheimer's disease cases were less likely to exist in cases of dementia with a history of stoke.
In conclusion, our prospective study showed that smoking was associated with an increased risk of disabling dementia. The smoking-dementia association did not vary by stroke history. A dose-response relationship was observed between the duration of smoking and the risk, and a twofold excess risk was found for smoking duration of 6 45 years. Long-term cigarette smoking may raise the risk of disabling dementia.
